Showing results (1411-1420 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|July 30, 2021
FLAMSA-Busulfan-Melphalan as a Sequential Conditioning Regimen in HLA-Matched or Haploidentical Hematopoietic Stem Cell Transplantation for High-Risk Myeloid DiseasesLudovic Jondreville, Damien Roos-Weil, Madalina Uzunov, et al.
Transplantation and Cellular Therapy|June 6, 2022
Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantationYuta Kawahara, Sae Ishimaru, Junji Tanaka, et al.
Transplantation and Cellular Therapy|June 6, 2022
Self-Efficacy for Symptom Management in Long-Term Adult Hematopoietic Stem Cell SurvivorsNosha Farhadfar, Michael T Weaver, Zeina Al-Mansour, et al.
Transplantation and Cellular Therapy|June 1, 2022
Mannan-Binding Lectin Promotes Murine Graft-versus-Host Disease by Amplifying Lipopolysaccharide-Initiated InflammationDavid Heja, Dongchang Zhao, Evan Cody, et al.
Transplantation and Cellular Therapy|June 22, 2022
Intramuscular Adipose Tissue Content Predicts Patient Outcomes after Allogeneic Hematopoietic Stem Cell TransplantationRyota Hamada, Tsugumi Asano, Masanobu Murao, et al.
Transplantation and Cellular Therapy|June 18, 2022
Clinical Features, Treatment, and Outcome of Pediatric Steroid Refractory Acute Graft-Versus-Host Disease: A Multicenter StudyAnne B Verbeek, Suze A Jansen, Erik G J von Asmuth, et al.
Transplantation and Cellular Therapy|June 17, 2022
Higher Dose of CD34+ cells Promotes Early Reconstitution of Natural Killer Cells and Is Associated with Better Outcomes After Unmanipulated Hematopoietic Stem Cell Transplantation for Myeloid MalignanciesFei Zhao, Yuanyuan Shi, Xin Chen, et al.
Transplantation and Cellular Therapy|June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple MyelomaSarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Transplantation and Cellular Therapy|June 3, 2021
Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow ProductsBrennan Parmelee Streck, Georges Naufal, George Carrum, et al.
Transplantation and Cellular Therapy|May 27, 2021
Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic MalignancyTakuto Takahashi, Aileen Scheibner, Qing Cao, et al.
Pageof 183